• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US UNK KNEE FEMORAL LCS; FEMORAL 

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US UNK KNEE FEMORAL LCS; FEMORAL  Back to Search Results
Catalog Number UNK KNEE FEMORAL LCS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Unspecified Infection (1930); Muscular Rigidity (1968); Thrombosis/Thrombus (4440)
Event Date 04/01/2023
Event Type  Injury  
Manufacturer Narrative
Product complaint#: (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes, or its employees that the report constitutes an admission that the product, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: gibbons jp, cassidy rs, bryce l, napier rj, bloch bv, beverland de.Is cementless total knee arthroplasty safe in women over 75 y of age? j arthroplasty.2023 apr;38(4):691-699.Doi: 10.1016/j.Arth.2022.10.021.Epub 2022 oct 19.Pmid: 36272510.Objective and methods: background: cementless total knee arthroplasty (tka) is the subject of renewed interest.Previous concerns about survivorship have been addressed and there is an appeal in terms of biological fixation and surgical efficiency.However, even surgeon advocates have concerns about the risk of marked subsidence when using this technology in older patients at risk for osteoporosis.Methods: this was a retrospective analysis of 1,000 consecutive fully cementless mobile bearing lcs complete rp tkas implanted between july 1, 2009 and february 28, 2019 on women over 75 years of age who had postoperative and 1-year x-rays.No patellas were resurfaced.The primary outcome was the incidence of subsidence.Results: there were three asymptomatic cases with definite subsidence and change in alignment.In a fourth symptomatic case, the femoral component subsided into varus and the tibia into valgus, thus maintaining alignment which facilitated nonoperative treatment in a 92-year-old.Overall, at 1 year, there were two- liner revisions for infection without recurrence.Five patients had further surgery, of which three were washouts and two were for periprosthetic fractures sustained postoperatively within 1 year.Seven patients had further anesthesia, of which five were manipulations and two were nonrecurrent closed reductions for spinouts.Lot, model and catalog number are not available, but the suspected depuy device possibly associated with reported adverse events: cementless lcs complete rp tka including femoral component, tibial tray, and tibial insert.Adverse event(s) and provided interventions associated with depuy devices: radiographic results without identified treatment: 3 reports of radiolucent lines with tibial subsidence- no treatment provided non-patient specific results: 3 revisions of the liner to treat infection 5 muas to treat stiffness 2 closed reductions to treat spin-out 2 dvts- treatment unknown 17 pulmonary embolisms- treatment unknown patient specific results: fig.4: 92-year-old female patient with tibial and femoral subsidence identified on day 15, causing varus/valgus misalignment.Treated with a knee brace and non-weightbearing.Fig.5: female patient reported pain at 11 days post-op.Radiographs identified a periprosthetic femoral fracture and notching.Treated with orif.Fig.6: female patient with pain and femoral fracture secondary to a fall 61 days post-implantation.Treated with orif.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.This complaint was opened to document complaints derived through a journal article review.Follow-ups were done to try and obtain additional information from the author of the journal article.No further information was received.As part of our company quality system process, all devices are manufactured, inspected, and distributed to approved specifications.Additional complaint information monitoring for potential safety signals will be conducted through complaint trending as part of the post-market surveillance.If additional information is made available, the investigation will be updated as applicable.Device history lot : the device lot number is unknown, therefore a device history review could not be performed.  if the lot/serial number becomes available, the record will be re-assessed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK KNEE FEMORAL LCS
Type of Device
FEMORAL 
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
Manufacturer (Section G)
JTE WARSAW MFG SITE
700 orthopaedic drive
warsaw IN
Manufacturer Contact
kate karberg
700 orthpaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key18044490
MDR Text Key327019113
Report Number1818910-2023-22113
Device Sequence Number1
Product Code JWH
Combination Product (y/n)N
Reporter Country CodeEI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK KNEE FEMORAL LCS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/20/2023
Initial Date FDA Received10/31/2023
Supplement Dates Manufacturer Received11/02/2023
Supplement Dates FDA Received11/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-